173 related articles for article (PubMed ID: 34349769)
1. Assessment of Expression of
Taheri M; Sangseifid S; Shahani P; Eftekharian MM; Arsang-Jang S; Ghafouri-Fard S
Front Immunol; 2021; 12():712859. PubMed ID: 34349769
[TBL] [Abstract][Full Text] [Related]
2. Expression Analysis of Protein Inhibitor of Activated STAT in Inflammatory Demyelinating Polyradiculoneuropathy.
Ghafouri-Fard S; Hussen BM; Nicknafs F; Nazer N; Sayad A; Taheri M
Front Immunol; 2021; 12():659038. PubMed ID: 34054823
[TBL] [Abstract][Full Text] [Related]
3. A Diagnostic Panel for Acquired Immune-Mediated Polyneuropathies Based on the Expression of lncRNAs.
Hussen BM; Nicknafs F; Hidayat HJ; Sayad A; Ghafouri-Fard S; Taheri M
Front Immunol; 2021; 12():643615. PubMed ID: 33708228
[TBL] [Abstract][Full Text] [Related]
4. SOCS gene family expression profile in the blood of multiple sclerosis patients.
Toghi M; Taheri M; Arsang-Jang S; Ohadi M; Mirfakhraie R; Mazdeh M; Sayad A
J Neurol Sci; 2017 Apr; 375():481-485. PubMed ID: 28196747
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of BDNF, BACE1 and their antisense transcripts in inflammatory demyelinating polyradiculoneuropathy.
Ghafouri-Fard S; Mazdeh M; Nicknafs F; Nazer N; Sayad A; Taheri M
Mult Scler Relat Disord; 2021 Jan; 47():102613. PubMed ID: 33160139
[TBL] [Abstract][Full Text] [Related]
6. Increased Levels of IL-34 in Acquired Immune-Mediated Neuropathies.
Rezaei S; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM
J Mol Neurosci; 2021 Jan; 71(1):137-141. PubMed ID: 32588399
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer.
Ghafouri-Fard S; Oskooei VK; Azari I; Taheri M
World J Surg Oncol; 2018 Nov; 16(1):226. PubMed ID: 30453988
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of cytokine transcripts in inflammatory demyelinating polyradiculoneuropathy.
Nicknafs F; Ghafouri-Fard S; Omrani MD; Nazer N; Sayad A; Taheri M
Metab Brain Dis; 2021 Oct; 36(7):2111-2118. PubMed ID: 34169408
[TBL] [Abstract][Full Text] [Related]
9. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
[TBL] [Abstract][Full Text] [Related]
10. Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX.
Paramanathan S; Tankisi H; Andersen H; Fuglsang-Frederiksen A
Clin Neurophysiol; 2016 Jan; 127(1):898-904. PubMed ID: 26049677
[TBL] [Abstract][Full Text] [Related]
11. Changes in the expression of suppressor of cytokine signalling (SOCS) 2 in the colonic mucosa of acromegalic patients are associated with hyperplastic polyps.
Bogazzi F; Ultimieri F; Raggi F; Russo D; Costa A; Marciano E; Bartalena L; Martino E
Clin Endocrinol (Oxf); 2009 Jun; 70(6):898-906. PubMed ID: 18844680
[TBL] [Abstract][Full Text] [Related]
12. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
[TBL] [Abstract][Full Text] [Related]
13. Over-Expression of Immune-Related lncRNAs in Inflammatory Demyelinating Polyradiculoneuropathies.
Sadeghpour S; Ghafouri-Fard S; Mazdeh M; Nicknafs F; Nazer N; Sayad A; Taheri M
J Mol Neurosci; 2021 May; 71(5):991-998. PubMed ID: 33057965
[TBL] [Abstract][Full Text] [Related]
14. Chronic Immune-Mediated Polyneuropathies.
Cox SZ; Gwathmey KG
Clin Geriatr Med; 2021 May; 37(2):327-345. PubMed ID: 33858614
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells.
Kim MH; Kim MS; Kim W; Kang MA; Cacalano NA; Kang SB; Shin YJ; Jeong JH
PLoS One; 2015; 10(4):e0123133. PubMed ID: 25849377
[TBL] [Abstract][Full Text] [Related]
16. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
[TBL] [Abstract][Full Text] [Related]
17. SOCS3 and SOCS5 mRNA expressions may predict initial steroid response in nephrotic syndrome children.
Ostalska-Nowicka D; Smiech M; Jaroniec M; Zaorska K; Zawierucha P; Szaflarski W; Malinska A; Nowicki M
Folia Histochem Cytobiol; 2011; 49(4):719-28. PubMed ID: 22252769
[TBL] [Abstract][Full Text] [Related]
18. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
[TBL] [Abstract][Full Text] [Related]
19. The expression of SOCS is altered in rheumatoid arthritis.
Isomäki P; Alanärä T; Isohanni P; Lagerstedt A; Korpela M; Moilanen T; Visakorpi T; Silvennoinen O
Rheumatology (Oxford); 2007 Oct; 46(10):1538-46. PubMed ID: 17726036
[TBL] [Abstract][Full Text] [Related]
20. Assessment of IL-38 Levels in Patients with Acquired Immune-Mediated Polyneuropathies.
Ali ZPM; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM
J Mol Neurosci; 2020 Sep; 70(9):1385-1388. PubMed ID: 32367504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
